Characterization of responses elicited by Toll-like receptor agonists in cells of the bursa of Fabricius in chickens

被引:28
|
作者
St Paul, Michael [1 ]
Paolucci, Sarah [1 ]
Read, Leah R. [1 ]
Sharif, Shayan [1 ]
机构
[1] Univ Guelph, Dept Pathobiol, Ontario Vet Coll, Guelph, ON N1G 2W1, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
B cells; Bursa of Fabricius; Chicken; Innate response; Toll-like receptor; TLR3; TLR4; TLR21; PLASMACYTOID DENDRITIC CELLS; ANTIGEN-PRESENTING CELLS; NAIVE B-CELLS; GENE-EXPRESSION; IMMUNE-SYSTEM; STIMULATION; DISTINCT; SUBSETS; IL-10; TLR9;
D O I
10.1016/j.vetimm.2012.07.008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toll-like receptors (TLRs) are an evolutionarily conserved group of pattern recognition receptors that play an important role in mediating host-responses to pathogens. Several TLRs have been identified in chickens and their expression has been detected in many immune cell subsets including in B cells. However, the mechanisms through which TLRs modulate B cell responses have not been well characterized in chickens. The aim of the present study was to elucidate the responses mounted by cells of the bursa of Fabricius to treatment with the TLR 3, 4 and 21 ligands, poly I:C, lipopolysaccharide (LPS) and CpG oligodeoxynucleotides (ODN), respectively. The relative expression of several immune system genes was quantified at 1, 3, 8 and 18h post-treatment. The results show that all three ligands induced the up-regulation of interferon (IFN)-gamma and interleukin (IL)-10 transcripts and promoted the up-regulation of transcripts associated with antigen presentation, namely CD80 and major histocompatibility complex (MHC) class II. Furthermore, the results indicated that LPS and poly I:C induced the greatest IFN-gamma and IL-10 responses, respectively, while CpG ODN was the most efficacious inducer of CD80 and MHC-II expression. Future studies may be aimed at elucidating the mechanisms of TLR-mediated activation of chicken B cells. These mechanisms may be then exploited for the development of adjuvants with enhanced ability to stimulate B cell responses. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:237 / 244
页数:8
相关论文
共 50 条
  • [21] Facile syntheses of functionalized toll-like receptor 7 agonists
    Akinbobuyi, Babatope
    Byrd, Matthew R.
    Chang, Charles A.
    Nguyen, Mysa
    Seifert, Zacharie J.
    Flamar, Anne-Laure
    Zurawski, Gerard
    Upchurch, Katherine C.
    Oh, SangKon
    Dempsey, Stephen H.
    Enke, Thomas J.
    Le, John
    Winstead, Hunter J.
    Boquin, Jose R.
    Kane, Robert R.
    TETRAHEDRON LETTERS, 2015, 56 (02) : 458 - 460
  • [22] Trial Watch Toll-like receptor agonists for cancer therapy
    Vacchelli, Erika
    Eggermont, Alexander
    Sautes-Fridman, Catherine
    Galon, Jerome
    Zitvogel, Laurence
    Kroemer, Guido
    Galluzzi, Lorenzo
    ONCOIMMUNOLOGY, 2013, 2 (08):
  • [23] Menstrual Cycle Influences Toll-Like Receptor Responses
    Dennison, Una
    McKernan, Declan P.
    Scully, Paul
    Clarke, Gerard
    Cryan, John
    Dinan, Timothy
    NEUROIMMUNOMODULATION, 2012, 19 (03) : 171 - 179
  • [24] The effects of administration of ligands for Toll-like receptor 4 and 21 against Marek's disease in chickens
    Parvizi, Payvand
    Abdul-Careem, Mohamed Faizal
    Mallick, Amirul Islam
    Haq, Kamran
    Haghighi, Hamid R.
    Orouji, Shahriar
    Heidari, Mohammad
    Behboudi, Shahriar
    Sharif, Shayan
    VACCINE, 2014, 32 (17) : 1932 - 1938
  • [25] Toll-like receptor pathways and innate responses to allografts
    Walker, Wendy E.
    Goldstein, Daniel R.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2007, 12 (01) : 5 - 9
  • [26] Porcine B Cell Subset Responses to Toll-like Receptor Ligands
    Braun, Roman Othmar
    Python, Sylvie
    Summerfield, Artur
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [27] Modulation of B cell responses by Toll-like receptors
    Booth, Jayaum
    Wilson, Heather
    Jimbo, Steve
    Mutwiri, George
    CELL AND TISSUE RESEARCH, 2011, 343 (01) : 131 - 140
  • [28] Cathepsins are required for toll-like receptor 9 responses
    Matsumoto, Fumi
    Saitoh, Shin-ichiroh
    Fukui, Ryutaroh
    Kobayashi, Toshihiko
    Tammura, Natsuko
    Konnio, Kazunori
    Kusumoto, Yutaka
    Akashi-Takamura, Sachiko
    Miyake, Kensuke
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 367 (03) : 693 - 699
  • [29] Advances in the design and delivery of peptide subunit vaccines with a focus on Toll-like receptor agonists
    Black, Matthew
    Trent, Amanda
    Tirrell, Matthew
    Olive, Colleen
    EXPERT REVIEW OF VACCINES, 2010, 9 (02) : 157 - 173
  • [30] Trial Watch Experimental Toll-like receptor agonists for cancer therapy
    Galluzzi, Lorenzo
    Vacchelli, Erika
    Eggermont, Alexander
    Fridman, Wolf Herve
    Galon, Jerome
    Sautes-Fridman, Catherine
    Tartour, Eric
    Zitvogel, Laurence
    Kroemer, Guido
    ONCOIMMUNOLOGY, 2012, 1 (05): : 699 - 716